Loss of NGF-TrkA signaling from the CNS is not sufficient to induce cognitive impairments in young adult or intermediate-aged mice

Journal of Neuroscience

Volumn 32, Issue 43, 2012, Pages 14885-14898

  Müller, Markus ^a   Triaca, Viviana ^a   Besusso, Dario ^a,b   Costanzi, Marco ^c,d   Horn, Jacqueline M ^b   Koudelka, Juraj ^b   Geibel, Mirjam ^b   Cestari, Vincenzo ^c,d   Minichiello, Liliana ^a,b  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c CNR   (Italy)

^d LUMSA UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; GLYCOPROTEIN GP 140; NERVE GROWTH FACTOR; NESTIN; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; CELL COUNT; CHOLINERGIC NERVE CELL; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEAR; FOREBRAIN; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NICK END LABELING; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

AGING; ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; AVOIDANCE LEARNING; CELL COUNT; CENTRAL NERVOUS SYSTEM; CHOICE BEHAVIOR; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC NEURONS; COGNITION DISORDERS; CONDITIONING (PSYCHOLOGY); CUES; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEAR; IN SITU NICK-END LABELING; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84867821355     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2849-12.2012     Document Type: Article

References (43)

1. Ammassari-Teule M, Hoffmann HJ, Rossi-Arnaud C (1993) Learning in inbred mice: strain-specific abilities across three radial maze problems. Behav Genet 23:405-412.
2. Baron SP, Meltzer LT (2001) Mouse strains differ under a simple schedule of operant learning. Behav Brain Res 118:143-152.
3. Baxter MG, Chiba AA (1999) Cognitive functions of the basal forebrain. Curr Opin Neurobiol 2:178-183.
4. Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory.' Nat Protoc 1:1306-1311.
5. Cave CB, Squire LR (1991) Equivalent impairment of spatial and nonspatial memory following damage to the human hippocampus. Hippocampus 1:329-340.
6. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, McMahon SB, Shelton DL, Levinson AD (1994) Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76:1001-1011.
7. Dechant G, Barde YA (2002) The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neu-rosci 5:1131-1136.
8. Di Patre PL, Mathes CW, Butcher LL (1993) Differential visualization of cholinest-erasic neuronal somata and fibers by use of modifications of acetylcholinesterase pharmacohistochemistry. J Histochem Cytochem 41:129 -135.
9. Fagan AM, Garber M, Barbacid M, Silos-Santiago I, Holtzman DM (1997) A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo. J Neurosci 17:7644-7654.
10. Fahnestock M, Michalski B, Xu B, Coughlin MD (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 18:210-220.
11. Higgins GA, Breysse N (2008) Rodent model of attention: the 5-choice serial reaction time task. Curr Protoc Pharmacol 5:5.49.
12. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677-736.
13. Humby T, Laird FM, Davies W, Wilkinson LS (1999) Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur J Neurosci 11:2813-2823.
14. Kitt CA, Höhmann C, Coyle JT, Price DL (1994) Cholinergic innervation of mouse forebrain structures. J Comp Neurol 341:117-129.
15. Large TH, Bodary SC, Clegg DO, Weskamp G, Otten U, Reichardt LF (1986) Nerve growth factor gene expression in the developing rat brain. Science 234:352-355.
16. Lee B, Tumu P, Paul IA (2002) Effects of LP-BM5 murine leukemia virus infection on errors and response time in a two-choice serial reaction time task in C57BL/6 mice. Brain Res 948:1-7.
17. Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294:1945-1948.
18. Lu B, Buck CR, Dreyfus CF, Black IB (1989) Expression of NGF and NGF receptor mRNAs in the developing brain: evidence for local delivery and action of NGF. Exp Neurol 104:191-199.
19. Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6:603-614.
20. Medina DL, Sciarretta C, Calella AM, Von Bohlen Und Halbach O, Unsicker K, Minichiello L (2004) TrkB regulates neocortex formation through the Shc/PLCgamma-mediated control of neuronal migration. EMBO J 23:3803-3814.
21. Minichiello L, Korte M, Wolfer D, Kühn R, Unsicker K, Cestari V, Rossi-Arnaud C, Lipp HP, Bonhoeffer T, Klein R (1999) Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24:401-414.
22. Minichiello L, Calella AM, Medina DL, Bonhoeffer T, Klein R, Korte M (2002) Mechanism of TrkB-mediated hippocampal long-term potentia-tion. Neuron 36:121-137.
23. Mobley WC, Woo JE, Edwards RH, Riopelle RJ, Longo FM, Weskamp G, Otten U, Valletta JS, Johnston MV (1989) Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen. Neuron 3:655- 664.
24. Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU (1997) Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 146:91-103.
25. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T (1999) Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol 57:451-484.
26. Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH (2000) Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 427:19-30.
27. Mufson EJ, Counts SE, Perez SE, Ginsberg SD (2008) Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother 8:1703-1718.
28. Naumann T, Casademunt E, Hollerbach E, Hofmann J, Dechant G, Frotscher M, Barde YA (2002) Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J Neurosci 22:2409-2418.
29. Paxinos G, Franklin KB (2001) The mouse brain in stereotaxic coordinates, Ed. 2. San Diego: Academic.
30. Peng S, Wuu J, Mufson EJ, Fahnestock M (2004) Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63:641-649.
31. Pisani A, Bernardi G, Ding J, Surmeier DJ (2007) Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 30:545-553.
32. Rodríguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R, Stewart AF, Dymecki SM (2000) High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet 25:139-140.
33. Sanchez-Ortiz E, Yui D, Song D, Li Y, Rubenstein JL, Reichardt LF, Parada LF (2012) TrkA gene ablationinbasal forebrain results indysfunction of the cholinergic circuitry. J Neurosci 32:4065-4079.
34. Scott J, Selby M, Urdea M, Quiroga M, Bell GI, Rutter WJ (1983) Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature 302:538-540.
35. Seidah NG, Benjannet S, Pareek S, Savaria D, Hamelin J, Goulet B, Laliberte J, Lazure C, Chrétien M, Murphy RA (1996) Cellular processing of the nerve growth factor precursor by the mammalian pro-protein converta-ses. Biochem J 314:951-960.
36. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barba-cid M (1994) Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368:246-249.
37. Sobreviela T, Clary DO, Reichardt LF, Brandabur MM, Kordower JH, Mufson EJ (1994) TrkA-immunoreactive profiles in the central nervous system: colo-calization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J Comp Neurol 350:587- 611.
38. Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signaling, neuro protection, and neural repair. Annu Rev Neurosci 24:1217-1281.
39. Squire LR, Cave CB (1991) The hippocampus, memory, and space. Hippocampus 1:269-271.
40. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schütz G (1999) Disruption of the glucocorticoid receptor genein the nervous system results in reduced anxiety. Nat Genet 23:99-103.
41. Ullrich A, Gray A, Berman C, Dull TJ (1983) Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature 303:821- 825.
42. Yeo TT, Chua-Couzens J, Butcher LL, Bredesen DE, Cooper JD, Valletta JS, Mobley WC, Longo FM (1997) Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J Neurosci 17:7594-7605.
43. Zhang ZW, Kang JI, Vaucher E (2011) Axonal varicosity density as an index of local neuronal interactions. PLoS One 6:e22543.